SELLAS Life Sciences SLS
NASDAQ SLS
$12.14 +0.16 (+1.34%)
At close: Oct 21, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Other financing activities (2017)

Updated

SELLAS Life Sciences' Other financing activities came in at $527,000 for FY2025, up 723.4% from $64,000 in FY2024.

Analysis

SELLAS Life Sciences (SLS) Other financing activities (2017) Analysis & Trends

  • Per Business Quant, earlier years put Other financing activities at $64,000 in FY2024 (+106.5%) and $31,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 SELLAS Life Sciences 2.30 Bn 1.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -1.20 Mn
API Access

SELLAS Life Sciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SLS&period=max&api_key=YOUR_API_KEY